TGF-β1

Fengyu Chen1, Qi Wang1, Yujin Li1

  • 1Department of Hematology, The First People's Hospital of Yunnan Province, Yunnan Province Clinical Research Center for Hematologic Disease, Yunnan Province Clinical Center for Hematologic Disease, Yunnan Provincial Clinical Medical Center for Blood Diseases and Thrombosis Prevention and Treatment, Kunming, Yunnan, China; Department of Hematology, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.

Experimental eye research
|November 22, 2024
PubMed
概括

转化视网膜静脉封闭 (RVO) 治疗,这项研究揭示了转化生长因子β1 (TGF-β1) 作为视网膜内皮细胞亡的关键驱动因素. 抑制TGF-β1通路为RVO提供了一个有前途的治疗策略.